The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Prospective cohort study of spinal muscular atrophy types 2 and 3
Open accessAbstract
OBJECTIVE: To characterize the natural history of spinal muscular atrophy type 2 and type 3 (SMA 2/3) beyond 1 year and to report data on clinical and biological outcomes for use in trial planning. METHODS: We conducted a prospective observational cohort study of 79 children and young adults with SMA 2/3 who participated in evaluations for up to 48 months. Clinically, we evaluated motor and pulmonary function, quality of life, and muscle strength. We also measured SMN2 copy number, hematologic and biochemical profiles, muscle mass by dual x-ray absorptiometry (DXA), and the compound motor action potential (CMAP) in a hand muscle. Data were analyzed for associations between clinical and biological/laboratory characteristics cross-sectionally, and for change over time in outcomes using all available data. RESULTS: In cross-sectional analyses, certain biological measures (specifically, CMAP, DXA fat-free mass index, and SMN2 copy number) and muscle strength measures were associated with motor function. Motor and pulmonary function declined over time, particularly at time points beyond 12 months of follow-up. CONCLUSION: The intermediate and mild phenotypes of SMA show slow functional declines when observation periods exceed 1 year. Whole body muscle mass, hand muscle compound motor action potentials, and muscle strength are associated with clinical measures of motor function. The data from this study will be useful for clinical trial planning and suggest that CMAP and DXA warrant further evaluation as potential biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61602-x · Cited by 21,320
Varni, J. W., Seid, M., & Kurtin, P. S. (2001) · Medical Care · doi:10.1097/00005650-200108000-00006 · Cited by 5,131
Dual Energy X-Ray Absorptiometry Body Composition Reference Values from NHANES
Kelly, T. L., Wilson, K. E., & Heymsfield, S. B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007038 · Cited by 1,026
Lunn, M. R., & Wang, C. H. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60921-6 · Cited by 995
Missing Data in Clinical Studies
Molenberghs, G., & Kenward, M. G. (2007) · Wiley eBooks · doi:10.1002/9780470510445 · Cited by 962
Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy.
Pearn, J. (1978) · Journal of Medical Genetics · doi:10.1136/jmg.15.6.409 · Cited by 472
An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients
O’Hagen, J. M., Glanzman, A. M., McDermott, M. P., Ryan, P. A., Flickinger, J., Quigley, J., Riley, S., Sanborn, E., Irvine, C., Martens, W. B., et al. (2007) · Neuromuscular Disorders · doi:10.1016/j.nmd.2007.05.009 · Cited by 380
Self-citationWirth, B., Brichta, L., Schrank, B., Lochmüller, H., Blick, S., Baasner, A., & Heller, R. (2006) · Human Genetics · doi:10.1007/s00439-006-0156-7 · Cited by 355
Relation of BMI to fat and fat-free mass among children and adolescents
Freedman, D. S., Wang, J., Maynard, L. M., Thornton, J. C., Mei, Z., Pierson, R. N., Dietz, W. H., & Horlick, M. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802735 · Cited by 352
De Novo and Inherited Deletions of the 5q13 Region in Spinal Muscular Atrophies
Melki, J., Lefebvre, S., Burglen, L., Burlet, P., Clermont, O., Millasseau, P., Reboullet, S., Bénichou, B., Zeviani, M., Le Paslier, D., et al. (1994) · Science · doi:10.1126/science.7910982 · Cited by 322
Bordet, T., Buisson, B., Michaud, M., Drouot, C., Galéa, P., Delaage, P., Akentieva, N. P., Evers, A. S., Covey, D. F., Ostuni, M. A., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.123000 · Cited by 266
Height prediction from ulna length
Gauld, L. M., Kappers, J., Carlin, J. B., & Robertson, C. F. (2004) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162204000787 · Cited by 238
Glanzman, A. M., O’Hagen, J. M., McDermott, M. P., Martens, W. B., Flickinger, J., Riley, S., Quigley, J., Montes, J., Dunaway, S., Deng, L., et al. (2011) · Journal of Child Neurology · doi:10.1177/0883073811420294 · Cited by 205
Self-citationSwoboda, K. J., Scott, C. B., Crawford, T. O., Simard, L. R., Reyna, S. P., Krosschell, K. J., Acsadi, G., Elsheik, B., Schroth, M. K., D'Anjou, G., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012140 · Cited by 174
Observational Study of Spinal Muscular Atrophy Type 2 and 3: Functional Outcomes Over 1 Year
Kaufmann, P. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.373 · Cited by 173
Self-citationRandomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy
Mercuri, E., Bertini, E., Messina, S., Solari, A., D'Amico, A., Angelozzi, C., Battini, R., Berardinelli, A., Boffi, P., Bruno, C., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000249142.82285.d6 · Cited by 172
Iannaccone, S. T., Hynan, L. S., Morton, A., Buchanan, R., Limbers, C. A., & Varni, J. W. (2009) · Neuromuscular Disorders · doi:10.1016/j.nmd.2009.09.009 · Cited by 164
A Phase 1 Trial of Riluzole in Spinal Muscular Atrophy
Russman, B. S., Iannaccone, S. T., & Samaha, F. J. (2003) · Archives of Neurology · doi:10.1001/archneur.60.11.1601 · Cited by 136
Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells
Grzeschik, S. M., Ganta, M., Prior, T. W., Heavlin, W. D., & Wang, C. H. (2005) · Annals of Neurology · doi:10.1002/ana.20548 · Cited by 113
Sproule, D. M., Montes, J., Montgomery, M., Battista, V., Koenigsberger, D. Y., Shen, W., Punyanitya, M., Vivo, D. C. D., & Kaufmann, P. (2009) · Neuromuscular Disorders · doi:10.1016/j.nmd.2009.03.009 · Cited by 104
Self-citationOutcome Measures for Pediatric Spinal Muscular Atrophy
Iannaccone, S. T. (2002) · Archives of Neurology · doi:10.1001/archneur.59.9.1445 · Cited by 98
Motor function–muscle strength relationship in spinal muscular atrophy
Merlini, L., Bertini, E., Minetti, C., Mongini, T., Morandi, L. O., Angelini, C. I., & Vita, G. (2004) · Muscle & Nerve · doi:10.1002/mus.20018 · Cited by 93
Nelson, L. L., Owens, H., Hynan, L. S., Iannaccone, S. T., & AmSMART Group (2006) · Neuromuscular Disorders · doi:10.1016/j.nmd.2006.03.005 · Cited by 87
Cited by
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
Mercuri, E., Darras, B. T., Chiriboga, C. A., Day, J. W., Campbell, C., Connolly, A. M., Iannaccone, S. T., Kirschner, J., Kuntz, N. L., Saito, K., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1710504 · Cited by 1,433
Self-citationMercuri, E., Finkel, R. S., Muntoni, F., Wirth, B., Montes, J., Main, M., Mazzone, E. S., Vitale, M., Snyder, B., Quijano-Roy, S., et al. (2018) · Neuromuscular Disorders · doi:10.1016/j.nmd.2017.11.005 · Cited by 1,055
Self-citationFinkel, R. S., Mercuri, E., Meyer, O. H., Simonds, A. K., Schroth, M. K., Graham, R. J., Kirschner, J., Iannaccone, S. T., Crawford, T. O., Woods, S., et al. (2018) · Neuromuscular Disorders · doi:10.1016/j.nmd.2017.11.004 · Cited by 684
Self-citationResults from a phase 1 study of nusinersen (ISIS-SMN Rx ) in children with spinal muscular atrophy
Chiriboga, C. A., Swoboda, K. J., Darras, B. T., Iannaccone, S. T., Montes, J., De Vivo, D. C., Norris, D. A., Bennett, C. F., & Bishop, K. M. (2016) · Neurology · doi:10.1212/wnl.0000000000002445 · Cited by 612
Self-citationKolb, S. J., & Kissel, J. T. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.07.004 · Cited by 603
Metadata
- Authors
- Kaufmann, P., McDermott, M. P., Darras, B. T., Finkel, R. S., Sproule, D. M., Kang, P. B., Oskoui, M., Constantinescu, A., Gooch, C. L., Foley, A. R., Yang, M. L., Tawil, R., Chung, W. K., Martens, W. B., Montes, J., Battista, V., O'Hagen, J., Dunaway, S., Flickinger, J., Quigley, J., Riley, S., Glanzman, A. M., Benton, M., Ryan, P. A., Punyanitya, M., Montgomery, M. J., Marra, J., Koo, B., & De Vivo, D. C.
- Venue
- Neurology
- Published
- 2012-10-30
- Volume
- 79
- Issue
- 18
- Pages
- 1889-1897
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W1985468175
- Cited by
- 283
- References
- 24
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.